Management of Glucocorticoid-Induced Osteoporosis

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

(2011) M. Marenzana et al.   ARTHRITIS AND RHEUMATISM

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2011) Adolfo Díez-Pérez et al.   BONE

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis

(2011) René Rizzoli et al.   CALCIFIED TISSUE INTERNATIONAL

Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?

(2011) Juliet Compston   CLINICAL ENDOCRINOLOGY

Bioavailability and Short-Term Tolerability of Alendronate in Glucocorticoid-Treated Children

(2011) Meranda Nakhla et al.   CLINICAL THERAPEUTICS

Osteoprotegerin Prevents Glucocorticoid-Induced Osteocyte Apoptosis in Mice

(2011) Robert S. Weinstein et al.   ENDOCRINOLOGY

An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation

(2011) Alexander Rauch et al.   FASEB JOURNAL

Glucocorticoid dose determines osteocyte cell fate

(2011) Junjing Jia et al.   FASEB JOURNAL

Official Positions for FRAX® Clinical Regarding Glucocorticoids: The Impact of the Use of Glucocorticoids on the Estimate by FRAX® of the 10 Year Risk of Fracture

(2011) Edward S. Leib et al.   JOURNAL OF CLINICAL DENSITOMETRY

Matrix-embedded cells control osteoclast formation

(2011) Jinhu Xiong et al.   NATURE MEDICINE

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

(2011) Tomoki Nakashima et al.   NATURE MEDICINE

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Advances in Glucocorticoid-Induced Osteoporosis

(2011) Debby den Uyl et al.   Current Rheumatology Reports

Impact of inhaled corticosteroids on cortisol suppression in adults with asthma: a quantitative review

(2010) John H. Wlodarczyk et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial

(2010) C. C. Mok et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of Alendronate and Strontium Ranelate on Cancellous and Cortical Bone Mass in Glucocorticoid-Treated Adult Rats

(2010) P. Sun et al.   CALCIFIED TISSUE INTERNATIONAL

How to prevent glucocorticoid-induced osteoporosis

(2010) R. K. DORE   CLEVELAND CLINIC JOURNAL OF MEDICINE

Role of the negative glucocorticoid regulatory element in glucocorticoid repression of the human osteocalcin promoter

(2010) Nigel Morrison et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Glucocorticoids are not always deleterious for bone

(2010) Antoon HJM van Lierop et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Management of glucocorticoid-induced osteoporosis

(2010) Juliet Compston   Nature Reviews Rheumatology

Osteocyte: the unrecognized side of bone tissue

(2010) G. Y. Rochefort et al.   OSTEOPOROSIS INTERNATIONAL

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

(2009) R. K. Dore et al.   ANNALS OF THE RHEUMATIC DISEASES

Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL

(2009) Lorenz C. Hofbauer et al.   ARTHRITIS AND RHEUMATISM

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial

(2009) Kenneth G. Saag et al.   ARTHRITIS AND RHEUMATISM

Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis

(2009) J.-P. DEVOGELAER et al.   JOURNAL OF RHEUMATOLOGY

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

(2009) David M Reid et al.   LANCET

Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells

(2009) Lorenz C. Hofbauer et al.   MOLECULAR ENDOCRINOLOGY

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

(2009) B. L. Langdahl et al.   OSTEOPOROSIS INTERNATIONAL

Discovery of selective glucocorticoid receptor modulators by multiplexed reporter screening

(2009) A. N. Gerber et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: A longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice

(2008) Wei Yao et al.   ARTHRITIS AND RHEUMATISM

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

(2008) Stanley B. Cohen et al.   ARTHRITIS AND RHEUMATISM

BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: Potential therapeutic targets for glucocorticoid-induced osteoporosis

(2008) Kumi Hayashi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fracture Risk Associated with Different Types of Oral Corticosteroids and Effect of Termination of Corticosteroids on the Risk of Fractures

(2008) Peter Vestergaard et al.   CALCIFIED TISSUE INTERNATIONAL

Efficacy of intravenous alendronate for the treatment of glucocorticoid-induced osteoporosis in children with autoimmune diseases

(2008) Yuzaburo Inoue et al.   CLINICAL RHEUMATOLOGY

Inhaled Corticosteroids and the Risk of Fractures in Older Adults

(2008) Mahyar Etminan et al.   DRUG SAFETY

Management of osteoporosis in children

(2008) Nicholas J Shaw   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Alendronate Protects Premenopausal Women from Bone Loss and Fracture Associated with High-dose Glucocorticoid Therapy

(2008) Yosuke Okada et al.   JOURNAL OF RHEUMATOLOGY

Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol

(2008) Seiji Takeda et al.   Modern Rheumatology

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

(2008) J. Compston et al.   OSTEOPOROSIS INTERNATIONAL

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL